CIK 0001228627
- Non-accelerated filer
- Smaller reporting company
Opus Genetics, Inc.
Sign in to watch- Ticker
- IRD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 113516358
- Phone
- +1 984-884-6030
- Business address
- 8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
- Former names
- Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
- 5 Insider Annual Insider Trading Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 4,021 shares (grant or award)
- 4 Grant or award Director acquired 2,949 shares (grant or award)
- 4 Open-market buy Director bought 8,250 shares at $3.65 ($30,113)
- 4 Open-market buy Director bought 2,000 shares at $3.50 ($7,000)
- 4 Grant or award Director acquired 2,135 shares (grant or award)
- 4 Grant or award Director acquired 2,912 shares (grant or award)
- 4 Open-market buy Director bought 12,631 shares at $4.75 ($59,997)
- 4 Open-market buy Director bought 20,000 shares at $4.57 ($91,400)
- 4 Grant or award Director acquired 2,083 shares (grant or award)
- 4 Grant or award Director acquired 2,840 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 9 of 21 · 403 filings